Xuxi Zhang
Table 1.2.1 Overview of the studies presented in the thesis Chapter Study design Study/data Sample Population in analysis Research focus Part 1 Health promotion for people with frailty 2 Cross‐ sectional UHCE Community‐ dwellers aged ≥70 years N= 2,167 The associations between physical, psychological and social frailty and health‐ related quality of life 3 Longitudinal UHCE Community‐ dwellers aged ≥70 years N= 1,735 The longitudinal associations between frequency of moderate PA and overall, physical, psychological and social frailty; the association between a 12‐month change in frequency of moderate PA and frailty 4 Cross‐ sectional UHCE Community‐ dwellers aged ≥70 years N= 2,250 The reliability and validity of the Tilburg Frailty Indicator in 5 European countries 5 Mixed‐ methods study UHCE Community‐ dwellers aged ≥70 years and professionals participating in UHCE approach N= 986 & 23 Evaluation of UHCE approach regarding process components: context, reach, dose delivered and received, satisfaction and experience Part 2 Health promotion for people with chronic conditions 6 Meta‐ analysis PubMed, Web of science, ScienceDir ect Adults with T2DM 20 RCTs (N = 4,494) To study the effects of different kinds of peer support on glycemic control, in terms of providers, types of support, intervention duration and effect duration 7 Meta‐ analysis PubMed, Embase and ScienceDir ect Adults with T2DM 22 RCTs (N= 22,511) To study the effects of different interventions targeting modifiable risk factors on DR 8 Design paper SEFAC Community‐ dwellers at risk of or with T2DM and/or CVD aged ≥50 years N/A Evaluation design of the SEFAC project aimed to empower citizens to self‐ manage their chronic conditions through the SEFAC intervention Abbreviations: UHCE = the Urban Health Centres Europe project; PA = physical activity; DR = diabetic retinopathy; SEFAC =the Social Engagement Framework for Addressing the Chronic‐disease‐ challenge project; RCTs= randomized control trials; T2DM = type 2 diabetes; CVD = cardiovascular disease 1 19 General introduction
Made with FlippingBook
RkJQdWJsaXNoZXIy ODAyMDc0